NPI: 1154579522 · SALISBURY, NC 28144 · Family Medicine Physician · NPI assigned 08/28/2008
Authorized official WALTON, LEEA controls 20+ related entities in our dataset. Read more
| Authorized Official | WALTON, LEEA (RCS MANAGER) |
| NPI Enumeration Date | 08/28/2008 |
Other providers sharing the same authorized official: WALTON, LEEA
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 11,206 | $265K |
| 2019 | 12,331 | $382K |
| 2020 | 6,437 | $289K |
| 2021 | 13,676 | $429K |
| 2022 | 24,242 | $403K |
| 2023 | 26,016 | $272K |
| 2024 | 24,117 | $64K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 10,791 | 9,088 | $636K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 7,026 | 5,955 | $559K |
| 99199 | Unlisted special service, procedure or report | 68,384 | 67,391 | $227K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1,751 | 1,591 | $163K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 1,360 | 1,241 | $134K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 2,969 | 2,611 | $125K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 511 | 446 | $51K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 524 | 465 | $50K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1,412 | 1,091 | $26K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 1,310 | 1,249 | $24K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 451 | 386 | $21K |
| 90472 | Immunization administration, each additional vaccine (list separately) | 630 | 610 | $17K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1,138 | 536 | $16K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1,600 | 1,440 | $15K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 158 | 93 | $5K |
| 36415 | Collection of venous blood by venipuncture | 2,168 | 1,934 | $4K |
| 96127 | 867 | 779 | $4K | |
| 90686 | 842 | 792 | $3K | |
| 90474 | 165 | 157 | $3K | |
| 90651 | 104 | 100 | $3K | |
| 90461 | 1,359 | 1,180 | $2K | |
| 99460 | 24 | 24 | $2K | |
| 99238 | Hospital discharge day management, 30 minutes or less | 25 | 24 | $2K |
| 90674 | 184 | 160 | $2K | |
| 90670 | 1,283 | 1,156 | $1K | |
| 0001A | 63 | 19 | $1K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 17 | 12 | $1K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 88 | 68 | $1K |
| 0002A | 20 | 18 | $907.67 | |
| 90734 | 125 | 106 | $771.15 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 48 | 37 | $671.49 |
| 99462 | 22 | 14 | $593.44 | |
| 99406 | 79 | 68 | $453.68 | |
| 96161 | 101 | 90 | $392.11 | |
| 87807 | 26 | 22 | $374.38 | |
| 90633 | 142 | 115 | $279.49 | |
| 90715 | 42 | 36 | $170.00 | |
| 81003 | 63 | 52 | $133.85 | |
| 92552 | 114 | 114 | $22.96 | |
| 99173 | 161 | 158 | $8.04 | |
| G8541 | Functional outcome assessment using a standardized tool not documented, reason not given | 1,132 | 823 | $0.00 |
| G8752 | Most recent systolic blood pressure < 140 mmhg | 274 | 199 | $0.00 |
| 4040F | 80 | 50 | $0.00 | |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 1,341 | 1,012 | $0.00 |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 270 | 202 | $0.00 |
| G8482 | Influenza immunization administered or previously received | 393 | 275 | $0.00 |
| 4004F | 140 | 116 | $0.00 | |
| 90648 | 38 | 38 | $0.00 | |
| G8484 | Influenza immunization was not administered, reason not given | 138 | 107 | $0.00 |
| 90710 | 106 | 86 | $0.00 | |
| G9899 | Screening, diagnostic, film, digital or digital breast tomosynthesis (3d) mammography results documented and reviewed | 72 | 50 | $0.00 |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 22 | 12 | $0.00 |
| 90649 | 25 | 19 | $0.00 | |
| 90698 | 690 | 598 | $0.00 | |
| G8432 | Depression screening not documented, reason not given | 850 | 610 | $0.00 |
| G8754 | Most recent diastolic blood pressure < 90 mmhg | 435 | 315 | $0.00 |
| 1036F | 723 | 503 | $0.00 | |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | 183 | 140 | $0.00 |
| G8536 | No documentation of an elder maltreatment screen, reason not given | 257 | 171 | $0.00 |
| 90680 | 494 | 438 | $0.00 | |
| G9902 | Patient screened for tobacco use and identified as a tobacco user | 68 | 59 | $0.00 |
| G8732 | No documentation of pain assessment, reason not given | 1,145 | 823 | $0.00 |
| 90688 | 20 | 20 | $0.00 | |
| G8419 | Bmi documented outside normal parameters, no follow-up plan documented, no reason given | 301 | 216 | $0.00 |
| 90744 | 148 | 133 | $0.00 | |
| 1101F | 144 | 102 | $0.00 | |
| 3017F | 361 | 269 | $0.00 | |
| 90696 | 12 | 12 | $0.00 | |
| G9906 | Patient identified as a tobacco user received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling and/or pharmacotherapy) | 16 | 13 | $0.00 |